CPT Pearl of the Week
December 20, 2024 - Gamma Hydroxybutyrate (GHB)
December 13, 2024 - Drug Induced Liver Injury
December 9, 2024 - Alcohol Withdrawal
November 27, 2024 - Salicylate Poisoning
November 5, 2024 - Grapefruit Juice & Oral Medication Toxicity
October 30, 2024 - SCARs: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
October 18, 2024 - SCARs: Acute Generalized Exanthematous Pustulosis (AGEP)
October 15, 2024 - Epidermal Necrolysis
September 17, 2024 - Drug Induced Lupus
September 5, 2024 - Acquired Methemoglobinemia
May 30, 2024 - Drug Induced Hyperthermia Acute Treatment
May 21, 2024 - Hydrogen Peroxide
March 21, 2024 - High Alert Medications
February 14, 2024 - Extravasation Injuries Part II
December 19, 2023 - Extravasation Injuries Part I
December 12, 2023 - Sugammadex
November 27, 2023 - Methotrexate Part II
October 31, 2023 - Tetracyclines in Pediatric Patients
September 14, 2023 - Drug Induced Brugada Syndrome
September 7, 2023 - Benzodiazepine Tapering
August 31, 2023 - P-glycoproteins
August 23, 2023 - Homeopathic Medicine
June 6, 2023 - Do Not Use Abbreviations
April 21, 2023 - Drug Induced Renal Tubular Acidosis
March 10, 2023 - Anabolic Steroids
January 31, 2023 - Pharmacovigilance
January 16, 2023 - Adverse Drug Reactions
December 19, 2022 - Flumazenil
December 5, 2022 - Extracorporeal Removal of Drugs
November 28, 2022 - Good Prescribing Practice
October 31, 2022 - Phenytoin Part 2
October 17, 2022 - Phenytoin Part 1
September 26, 2022 - Newer IV NAC Regimens Part 2
September 19, 2022 - Newer IV NAC Regimens Part 1
June 15, 2022 - Contrast Allergy
May 4, 2022 - IV NAC Neurotoxicity
February 25, 2022 - Drug Induced Movement Disorders
December 17, 2021 - Immune Checkpoint Inhibitors Part 1: Pharmacology and Indications
December 17, 2021 - Immune Checkpoint Inhibitors Part 2: Toxicity
December 17, 2021 - Immune Checkpoint Inhibitors Part 3: Management of Toxicity
November 16, 2021 - Statin Intolerance
October 18, 2021 - Carbon Monoxide (CO) Part 2: Testing and Treatment
October 12, 2021 - Carbon Monoxide (CO) Part 1: Sources and Symptoms
September 13, 2021 - Amiodarone Part 5: Lung Toxicity
September 3, 2021 - Ivermectin
July 14, 2021 - Amiodarone Part 4: Thyroid Toxicity
July 7, 2021 - Amiodarone Part 3: Ophthalmologic Toxicity
June 15, 2021 - Amiodarone Part 2: Neurotoxicity
June 7, 2021 - Amiodarone Part 1: Facts & Pharmacology
May 18, 2021 - Phencyclidine (PCP)
April 20, 2021 - Sodium Nitrite and Nitrate
April 15, 2021 - Fomepizole for Acetaminophen Toxicity
February 25, 2021 - Part 5 Hypertension Series Alpha-2 Adrenergic
February 10, 2021 - Part 4 Hypertension Series: Mineralocorticoid Receptor Antagonists (MRAs)
January 20, 2021 - Part 2 Toxicokinetics vs Pharmacokinetics: Distribution
December 7, 2020 - SGLT-2 Inhibitors
November 20, 2020 - Part 1 Toxicokinetics vs Pharmacokinetics: Absorption
November 6, 2020 - Part 3 Hypertension Series: Thiazide and Thiazide-like Diuretics
October 30, 2020 - Part 2 Hypertension Series: Cardio-selective Beta-blockers
October 14, 2020 - Part 1 Hypertension Series: Dihydropyridine Calcium Channel Blockers
September 25, 2020 - Hydroxychloroquine
August 24, 2020 - Pharmacogenomics and Immune Reactions
July 31, 2020 - Interpreting Pharmacogenomic Test Results
July 13, 2020 - Pharmacogenomics Pros and Cons
June 25, 2020 - Pharmacogenomics- How and Where?
June 12, 2020 - Introduction to Pharmacogenomics
May 19, 2020 - Personalized Medicine
May 5, 2020 - Restarting a medication after an adverse drug event
April 17, 2020 - Vancomycin induced AKI
March 24, 2020 - Medication errors and solutions, Part 2
March 13, 2020 - Medication errors and solutions, Part 1
February 7, 2020 - Clopidogrel and Clopidogrel non- responders
January 24, 2020 - Digoxin Monitoring
January 17, 2020 - Mechanisms of drug - drug interactions
January 3,2020 - Restarting a medication post-overdose
December 18,2019 - Introduction to Pharmacokinetics
December 6,2019 - Breastfeeding
November 22,2019 - Heparin- Induced Thrombocytopenia and Thrombosis ( HITT)
November 15, 2019- Drug- Induced Urinary Retention
November 8, 2019 - Hydroxocobalamin Cyanide Antidote
October 18, 2019 - Physostigmine for Anticholinergic Delirium
October 11, 2019 - Drug- Induced Prolonged QTc
September 27, 2019 - Intravenous lipid emulsion
September 13, 2019 - Nitrofurantoin, Part 2
September 6, 2019 - Nitrofurantoin, Part 1
August 23, 2019 - Drug-induced dysgeusia
August 16, 2019 - Medication safety, part 2 (deprescribing)
August 9, 2019 - Medication safety, part 1 (appropriate prescribing)
August 2, 2019 - Activated charcoal
July 27, 2019 - High Dose Insulin and Glucose
July 20, 2019 - Beers Criteria
June 21. 2019 - Drugs to avoid in G6PD deficiency
June 7/14, 2019 - Pros and Cons of Different DOACs
May 24, 2019 - Drug induced thrombocytopenia
May 17, 2019 - Drug induced hyperlactatemia
May 10, 2019 - Metformin associated lactic acidosis
May 3, 2019 - Propofol-related infusion syndrome
April 12, 2019 - Anaphylactoid reactions and IV NAC
March 22, 2019 - Drug-drug interactions and DOACs
March 15, 2019 - Drug-induced seizures
March 8, 2019 - ECG findings in sodium channel blocker toxicity
March 1, 2019 - Drug Induced Peripheral Edema
February 22, 2019 - Methotrexate
February 15, 2019 - Carbamazepine
February 8, 2019 - Drug-induced neutropenia
February 1, 2019 - Toxicologic Hyperthermic Syndromes, Part 2
January 18/25, 2019 - Toxicologic Hyperthermic Syndromes, Part 1